Table 6.
Summary of clinical studies with the use of autologous platelet gel.
| Reference | Year | Study Type | Medical Field | Patients in Study | Outcome Effect |
|---|---|---|---|---|---|
| 105 | 90 | PR | WC | 32 | + |
| 99 | 98 | PR | M-F | 88 | + |
| 106 | 99 | Case | M-F | 20 | + |
| 107 | 99 | R-case | SS* | 19 | +/− |
| 98 | 01 | Case | M-F | 3 | − |
| 108 | 01 | Case | ES | 121 | + |
| 100 | 01 | Case | CS | 20 | + |
| 28 | 01 | R-case | WC | 26.599 | + |
| 109 | 01 | Case | M-F | 3 | + |
| 110 | 01 | PR-B | CS | 8 | + |
| 3 | 01 | Case | M-F | 3 | − |
| 111 | 02 | Case | CS | 20 | + |
| 1 | 02 | Case | M-F | 3 | − |
| 102 | 02 | Case | M-F | 5 | + |
| 101 | 02 | Case | CS | 14 | + |
| 4 | 03 | Case | SS* | 57 | − |
| 112 | 04 | P-contr | SS* | 84 | − |
| 29 | 04 | Case | WC | 24 | + |
| 113 | 04 | Case-contr | M-F | 5 | + |
| 27 | 04 | Case | WC | 22 | + |
| 114 | 05 | PR | M-F | 18 | + |
| 5 | 05 | R-contr | SS* | 152 | − |
| 103 | 05 | R | CTS | 30 | + |
| 115 | 05 | Case | M-F | 8 | + |
| 116 | 05 | P-contr-B | M-F | 10 | + |
| 117 | 05 | PR | OS | 10 | + |
| 118 | 05 | Case-contr | M-F | 20 | + |
| 104 | 06 | PR | OS | 164 | + |
PR, prospective randomized; case, consecutive cases; R-case, retrospective case study consecutive cases; PR-B, prospective randomized blinded; case-contr, case study with patient being his/her own control; P-contr, prospective study with controls; R-contr, retrospective study with control patients; P-control-B, prospective consecutive study, single blinded; M-F, maxillo-facial surgery; WC, wound care; SS, spinal surgery; CS, cosmetic surgery; ES, eye surgery; OS, orthopaedic surgery; CTS, cardio thoracic surgery.
+, +/− means a positive, doubtful, and negative effect of PG treatment, respectively.